Skeletal-Related Events in Metastatic Prostate Cancer and the Number Needed to Treat: A Critical Consideration

By  

Urologia Internationalis, Vol. 90, Iss. 3, 2013-02 ,pp. : 329-333

Karger

Access to resources Recommend Favorite

Effects of drug treatment for malignancy on skeletal health of cancer survivors

By Heras-Herzig Ailleen   Guise Theresa  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 103-114

Humana Press, Inc

Access to resources Recommend Favorite

Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-09 ,pp. : 185-189

Bentham Science Publishers

Access to resources Recommend Favorite

Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI

By Schlander M.   Beck M.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1285-1293

Informa Healthcare

Access to resources Recommend Favorite

Insilico inhibition of hexokinase-2 to treat cancer cells

By Subhashini R.  

International Journal of Medical Engineering and Informatics, Vol. 5, Iss. 1, 2013-01 ,pp. : 1-4

Inderscience Publishers

Access to resources Recommend Favorite